Finance

BlackRock Capital Investment Garners Hold Rating From StockNews.com Analysts

Published February 17, 2024

In a recent development, StockNews.com's team of stock analysts has commenced coverage on the shares of BlackRock Capital Investment (NASDAQ:BKCC). The outcome of their analysis led to the issuance of a 'hold' rating to the asset management firm's stock, which was publicly reported on Saturday.

Recent Analyses and Stock Performance

Adding to the coverage, Wells Fargo & Company raised their price target on BlackRock Capital Investment shares from $3.50 to $3.75, maintaining an 'equal weight' rating on January 29th. On Friday, BKCC shares opened at $3.77. The stocks have fluctuated between a 52-week low of $3.03 and a 52-week high of $4.03. BlackRock Capital Investment has a market capitalization of roughly $273.59 million, a price-to-earnings ratio of 17.14, and exhibits a beta of 1.44. Moreover, the company's stock price is hovering around a 50-day simple moving average of $3.86 and a 200-day simple moving average of $3.70. The asset manager also reports a debt-to-equity ratio of 0.87, with a quick ratio and a current ratio both standing at 0.84.

Investor Movement

BlackRock Capital Investment witnessed notable activity from institutional investors. Notable movements include D.A. Davidson & CO.'s 8.2% increase in shareholdings during the fourth quarter, Great West Life Assurance Co. Can's 5.1% increase in the second quarter, and Private Advisor Group LLC's 34.6% hike in the same period. Ancora Advisors LLC increased its investment by 42.4% in the first quarter, while Tower Research Capital LLC TRC's holdings skyrocketed by 101.1% during the third quarter. Institutional investors own a combined total of 18.25% of BlackRock Capital Investment's stock.

About BlackRock Capital Investment

BlackRock Capital Investment Corporation, previously named BlackRock Kelso Capital Corporation, is known as a Business Development Company (BDC). This corporation specializes in middle market company investments across various industries. It strategically places capital injections between $10 million and $50 million into entities with an EBITDA or operating cash flow within the range of $10 million to $50 million.

BlackRock, Investment, Analyst